Related Experiment Video
Updated: Jan 23, 2026

Experimental Model of Ligature-Induced Peri-Implantitis in Mice
Published on: May 17, 2024
The influence of abutment macro-design on clinical and radiographic peri-implant tissue changes for guided, placed,
Theofilos Koutouzis1, Bashar Adeinat1, Abdulaziz Ali1
1Nova Southeastern University, Fort Lauderdale, Florida.
Objectives:
The aim was to evaluate the peri-implant tissue levels over a 1-year period for implants connected to either convex or concave final abutments at the time of implant placement.
Materials And Methods:
In this randomized, double masked, controlled clinical study, twenty-eight patients with one missing maxillary premolar were allocated to receive one single implant with abutment of either convex (CX Group) or concave (CV Group) emergence shape. A block randomization sequence was used to allocate treatments. Opaque sealed randomization envelopes were used for allocation concealment. All implants received final abutments and interim crowns at implant placement and permanent crowns following 3 months. Clinical and radiographic data were collected at the time of implant placement (IP), final prosthesis delivery (PR), and 12 months following implant placement (FU-1).
Results:
One patient from the CX Group (n = 13) dropped out from the study and for one patient from CV Group (n = 13), the implant failed to integrate. The mean change in peri-implant buccal mucosa position (MP) from IP to FU-1 was -0.76 ± 0.72 mm for CX Group and -0.69 ± 0.89 mm for CV Group (p = 0.8). The amount of bone remodeling above the implant platform from IP to FU-1 was -0.66 ± 0.46 mm for the CX Group and -0.24 ± 0.25 mm for the CV Group (p = 0.007). Buccal bone thickness was significantly correlated with the amount of buccal MP change from IP to FU-1 (r = 0.4, p = 0.038).
Conclusion:
The study failed to support the hypothesis that abutment macro-design has an effect on peri-implant mucosa margin position changes over time.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
PI Controller: Design
Statistical Software for Data Analysis and Clinical Trials

